Cormorant Asset Management, LP

Insider Reports History

Entity: Company
Location: 200 Clarendon Street, 52 Nd Floor, Boston, MA
Signature: CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cormorant Asset Management, LP:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Ambrx Biopharma Inc.	10%+ Owner	Ordinary Shares	69.5M	$642M	$9.24	Sep 18, 2023	Indirect
Ambrx Biopharma, Inc.	10%+ Owner	Common Stock	11.2M	$110M	$9.82	Oct 23, 2023	Indirect
EyePoint Pharmaceuticals, Inc.	10%+ Owner	Common Stock	8.33M	$103M	$12.36	May 6, 2024	Indirect
Monte Rosa Therapeutics, Inc.	Former 10% Owner	Common Stock	3.2M	$60.8M	$19.00	Jun 28, 2021	Indirect
Corbus Pharmaceuticals Holdings, Inc.	10%+ Owner	Common Stock	2.38M	$52.8M	$22.23	Sep 20, 2024	Indirect
Aerovate Therapeutics, Inc.	Former 10% Owner	Common Stock	2.03M	$39.6M	$19.50	Jul 2, 2021	Indirect
Verve Therapeutics, Inc.	Former 10% Owner	Common Stock	984K	$9.84M	$10.00	Jun 21, 2021	Indirect
Immuneering Corp	10%+ Owner	Class A Common Stock	2.9M	$8.6M	$2.97	Apr 1, 2024	Indirect
Tyra Biosciences, Inc.	Former 10% Owner	Common Stock	1.07M	$7.04M	$6.58	Sep 17, 2021	Indirect
Icosavax, Inc.	Former 10% Owner	Common Stock	426K	$6.68M	$15.67	Aug 2, 2021	Indirect
Ventyx Biosciences, Inc.	Former 10% Owner	Common Stock	1.41M	$2.99M	$2.12	Oct 25, 2021	Indirect
Vigil Neuroscience, Inc.	Former 10% Owner	Common Stock	617K	$2.31M	$3.75	Jan 11, 2022	Indirect
Pyxis Oncology, Inc.	Former 10% Owner	Common Stock	1.12M	$1.57M	$1.40	Oct 13, 2021	Indirect
Elevation Oncology, Inc.	Former 10% Owner	Common Stock	2.23M	$1.14M	$0.51	Jun 29, 2021	Indirect
Reneo Pharmaceuticals, Inc.	10%+ Owner	Class A Common Stock	1.84M			Oct 4, 2024	Indirect
BioAge Labs, Inc.	Former 10% Owner	Common Stock	1.63M			Sep 27, 2024	Indirect
BRIGHT MINDS BIOSCIENCES INC.	10%+ Owner	Common Shares	1.06M			Nov 4, 2024	Indirect
Aardvark Therapeutics, Inc.	Former 10% Owner	Common Stock	988K			Feb 14, 2025	Indirect
Aardvark Therapeutics, Inc.	Former 10% Owner	Series C Convertible Preferred Stock	0			Feb 14, 2025	Indirect
Aerovate Therapeutics, Inc.	Former 10% Owner	Series A Convertible Preferred Stock	0			Jul 2, 2021	Indirect
BioAge Labs, Inc.	Former 10% Owner	Series D Redeemable Convertible Preferred Stock	0			Sep 27, 2024	Indirect
Elevation Oncology, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Jun 29, 2021	Indirect
GreenLight Biosciences Holdings, PBC	Other*	Common Stock	0		$0.30	Jul 20, 2023	Indirect
Icosavax, Inc.	Former 10% Owner	Series B-1 Convertible Preferred Stock	0			Aug 2, 2021	Indirect
Monte Rosa Therapeutics, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0		$2.00	Jun 28, 2021	Indirect
Monte Rosa Therapeutics, Inc.	Former 10% Owner	Series C Convertible Preferred Stock	0			Jun 28, 2021	Indirect
Pyxis Oncology, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Oct 13, 2021	Indirect
Tyra Biosciences, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Sep 17, 2021	Indirect
Ventyx Biosciences, Inc.	Former 10% Owner	Series A Convertible Preferred Stock	0			Oct 25, 2021	Indirect
Ventyx Biosciences, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Oct 25, 2021	Indirect
Verve Therapeutics, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Jun 21, 2021	Indirect
Vigil Neuroscience, Inc.	Former 10% Owner	Series B Convertible Preferred Stock	0			Jan 11, 2022	Indirect

Previous1Next

Showing 1 to 32 of 32 entries

Insider Reports Filed by Cormorant Asset Management, LP

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
AARD	Aardvark Therapeutics, Inc.	Feb 14, 2025	3	$3M	4	Feb 19, 2025	Former 10% Owner
AARD	Aardvark Therapeutics, Inc.	Feb 12, 2025	0	$0	3	Feb 12, 2025	10%+ Owner
DRUG	BRIGHT MINDS BIOSCIENCES INC.	Nov 4, 2024	1	$4M	4	Nov 6, 2024	10%+ Owner
DRUG	BRIGHT MINDS BIOSCIENCES INC.	Oct 15, 2024	11	$3.23M	4	Oct 17, 2024	10%+ Owner
DRUG	BRIGHT MINDS BIOSCIENCES INC.	Oct 15, 2024	0	$0	3	Oct 17, 2024	10%+ Owner
OKUR	OnKure Therapeutics, Inc.	Oct 4, 2024	0	$0	3	Oct 15, 2024	10%+ Owner
BIOA	BioAge Labs, Inc.	Sep 27, 2024	3	$8.1M	4	Oct 1, 2024	Former 10% Owner
BIOA	BioAge Labs, Inc.	Sep 25, 2024	0	$0	3	Sep 25, 2024	10%+ Owner
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Sep 20, 2024	6	$7M	4	Sep 24, 2024	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	May 6, 2024	2	$10.1M	4	May 8, 2024	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	Apr 18, 2024	2	$10.5M	4	Apr 22, 2024	10%+ Owner
IMRX	Immuneering Corp	Apr 1, 2024	8	-$1.16M	4	Apr 3, 2024	10%+ Owner
IMRX	Immuneering Corp	Mar 14, 2024	5	-$2.75M	4	Mar 18, 2024	10%+ Owner
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Mar 7, 2024	10	$23.3M	4	Mar 11, 2024	10%+ Owner
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Feb 2, 2024	1	$14.3M	4	Feb 6, 2024	10%+ Owner
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Jan 26, 2024	14	$9.11M	4	Jan 30, 2024	10%+ Owner
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Jan 26, 2024	0	$0	3	Jan 30, 2024	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	Jan 9, 2024	2	$17.1M	4	Jan 11, 2024	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	Dec 8, 2023	1	$10M	4	Dec 12, 2023	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	Dec 4, 2023	17	$41.9M	4	Dec 6, 2023	10%+ Owner
EYPT	EyePoint Pharmaceuticals, Inc.	Dec 4, 2023	0	$0	3	Dec 6, 2023	10%+ Owner
AMAM	Ambrx Biopharma, Inc.	Oct 23, 2023	1	$9.14M	4	Oct 25, 2023	10%+ Owner
AMAM	Ambrx Biopharma Inc.	Sep 15, 2023	2	$19.6M	4	Sep 19, 2023	10%+ Owner
GRNA	GreenLight Biosciences Holdings, PBC	Jul 20, 2023	1	$0	4	Jul 24, 2023	Other*
GRNA	GreenLight Biosciences Holdings, PBC	May 29, 2023	0	$0	3	Jun 8, 2023	Other*
IMRX	Immuneering Corp	Apr 20, 2023	0	$0	3	Apr 24, 2023	10%+ Owner
AMAM	Ambrx Biopharma Inc.	Apr 18, 2023	3	$59M	4	Apr 20, 2023	10%+ Owner
AMAM	Ambrx Biopharma Inc.	Apr 13, 2023	3	$25.3M	4	Apr 17, 2023	10%+ Owner
AMAM	Ambrx Biopharma Inc.	Mar 14, 2023	3	$10.2M	4	Mar 16, 2023	10%+ Owner
AMAM	Ambrx Biopharma Inc.	Mar 3, 2023	0	$0	3	Mar 13, 2023	10%+ Owner
VIGL	Vigil Neuroscience, Inc.	Jan 11, 2022	2	$0	4	Jan 13, 2022	Former 10% Owner
VIGL	Vigil Neuroscience, Inc.	Jan 6, 2022	0	$0	3	Jan 6, 2022	10%+ Owner
VTYX	Ventyx Biosciences, Inc.	Oct 25, 2021	4	$10M	4	Oct 27, 2021	Former 10% Owner
VTYX	Ventyx Biosciences, Inc.	Oct 20, 2021	0	$0	3	Oct 20, 2021	10%+ Owner
PYXS	Pyxis Oncology, Inc.	Oct 13, 2021	3	$7.2M	4	Oct 15, 2021	Former 10% Owner
PYXS	Pyxis Oncology, Inc.	Oct 7, 2021	0	$0	3	Oct 7, 2021	10%+ Owner
TYRA	Tyra Biosciences, Inc.	Sep 17, 2021	3	$5M	4	Sep 21, 2021	Former 10% Owner
TYRA	Tyra Biosciences, Inc.	Sep 14, 2021	0	$0	3	Sep 14, 2021	10%+ Owner
IMRX	Immuneering Corp	Aug 3, 2021	3	$8.25M	4	Aug 5, 2021	Former 10% Owner
ICVX	Icosavax, Inc.	Aug 2, 2021	2	$0	4	Aug 4, 2021	Former 10% Owner
IMRX	Immuneering Corp	Jul 29, 2021	0	$0	3	Jul 29, 2021	10%+ Owner
ICVX	Icosavax, Inc.	Jul 28, 2021	0	$0	3	Jul 28, 2021	10%+ Owner
AVTE	Aerovate Therapeutics, Inc.	Jul 2, 2021	3	$7M	4	Jul 7, 2021	Former 10% Owner
ELEV	Elevation Oncology, Inc.	Jun 29, 2021	3	$4M	4	Jul 1, 2021	Former 10% Owner
AVTE	Aerovate Therapeutics, Inc.	Jun 29, 2021	0	$0	3	Jun 29, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 28, 2021	4	$11.4M	4	Jun 30, 2021	Former 10% Owner
ELEV	Elevation Oncology, Inc.	Jun 24, 2021	0	$0	3	Jun 24, 2021	10%+ Owner
GLUE	Monte Rosa Therapeutics, Inc.	Jun 23, 2021	0	$0	3	Jun 23, 2021	10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 21, 2021	3	$5.23M	4	Jun 23, 2021	Former 10% Owner
VERV	Verve Therapeutics, Inc.	Jun 16, 2021	0	$0	3	Jun 16, 2021	10%+ Owner